Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

This study has been withdrawn prior to enrollment.

Study NCT00334867 Information provided by National Cancer Institute (NCI)

First Received on June 7, 2006. Last Updated on January 2, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Sarcoma

Additional conditions recognized in this trial

Neuroectodermal Tumors, Primitive, Peripheral
Sarcoma, Ewing's

More general conditions related to this trial

Neoplasms
Neoplasms by Histologic Type
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Osteosarcoma

Interventions listed in this trial

cyclophosphamide
dexrazoxane hydrochloride
doxorubicin hydrochloride
etoposide
ifosfamide
topotecan hydrochloride
vincristine sulfate
conventional surgery
radiation therapy

Additional drug interventions recognized in this trial

Doxorubicin
Etoposide phosphate
Isophosphamide mustard
Razoxane
Topotecan
Vincristine

Sponsors listed in this trial

Children's Oncology Group
National Cancer Institute (NCI)

Back to top of Main Content